Scottish biotech company, Biotangents has launched AmpliSpec LAB Mastitis, its next-generation bovine mastitis diagnostic assay.

AmpliSpec LAB Mastitis uses isothermal amplification technology, which means laboratories can use less expensive equipment.

It also uses the company's lyophilised bead platform, designed to make the test stable and easy to use. 

Biotangents says its new test will offer notable cost, speed and accuracy benefits over the traditional culture and PCR testing used by animal health laboratories and veterinary clinics around the world. 

CEO Fiona Marshall said: “With 93% sensitivity and 95% specificity, this is a highly sophisticated assay that will help farmers, vets and laboratories to better treat mastitis.

http://www.biotangents.co.uk

PS: Whilst you're here, take a moment to see our latest job opportunities for vets.